Sign in
Insights Into the Progression of Diabetic Retinopathy Severity Among Primary Care Patients With Diabetes in the United States
Geeta A. Lalwani, MD
Annual Meeting Talks
2020
GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results
Jeffrey S. Heier, MD
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field
2022
One Year and Beyond: Results of Phase 1b Study of KSI-301, an AntiVEGF Antibody Biopolymer Conjugate With Extended Durability, in wAMD, DME, and RVO
Mark R. Barakat, MD
Category: AMD-Non-Neovascular